ILiAD Biotechnologies is focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Business Model:
Revenue: $0
Employees: 11-50
Address: 230 E 15th St
City: New York
State: NY
Zip: 10003
Country: US
ILiAD Biotechnologies is focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Contact Phone:
+19179138511
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Series D | 1 | $42.8M |
Knott Partners Knott Partners |
2/2016 | Equity | $955k | 12/2018 | Venture Round | 4 | $20M |
JEMS Venture Capital Network-1 SDS Capital Partners Seedlings Life Science Ventures JEMS Venture Capital Network-1 SDS Capital Partners Seedlings Life Science Ventures |
8/2016 | Seed Round | $545.8k | 10/2015 | Debt | $640k | 11/2015 | Debt Financing | $640k | 4/2022 | Grant | 1 | $1M |
National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases |
12/2018 | Equity | $5M |
Network-1 Technologies, Inc. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|